Growth retardation of fetal rats exposed to nicotine in utero: Possible involvement of CYP1A1, CYP2E1, and P-glycoprotein

Environmental Toxicology

Volumn 24, Issue 1, 2009, Pages 33-42

  Wang, Ting ^a   Chen, Man ^a   Yan, You E ^a   Xiao, Feng Qin ^a   Pan, Xiao Liang ^a   Wang, Hui ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Cytochrome p4501A1; Cytochrome P4502E1; Intrauterine growth retardation (IUGR); P glycoprotein; Prenatal nicotine exposure

Indexed keywords

CYTOCHROME P4501A1; CYTOCHROME P4502E1; INTRAUTERINE GROWTH RETARDATION (IUGR); P-GLYCOPROTEIN; PRENATAL NICOTINE EXPOSURE;

ALDEHYDES; ANIMALS; BIOACTIVITY; GENE EXPRESSION; GLYCOPROTEINS; GROWTH (MATERIALS); LIVER; RATS;

PYRIDINE;

COMPLEMENTARY DNA; CYTOCHROME P450 1A1; CYTOCHROME P450 2E1; GLYCOPROTEIN P; NICOTINE; RNA; TOBACCO SMOKE;

ALKALOID; BODY MASS; CYTOCHROME; GENE EXPRESSION; GROWTH RATE; INHIBITION; METABOLISM; MICROCOSM; PATHOLOGY; POLLUTION EXPOSURE; PREGNANCY; PROTEIN; RNA; RODENT; TOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CIGARETTE SMOKING; CLEFT PALATE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; ENZYME ASSAY; FETUS; FETUS DEVELOPMENT; FETUS MALFORMATION; GESTATIONAL AGE; INTRAUTERINE GROWTH RETARDATION; LIVER; LIVER MICROSOME; NONHUMAN; NUCLEOTIDE SEQUENCE; PLACENTA; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; BODY WEIGHT; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP2E1; FEMALE; FETUS; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LIVER; MALE; NICOTINE; P-GLYCOPROTEIN; PLACENTA; PREGNANCY; RATS; RATS, WISTAR; RNA, MESSENGER; SPECIFIC PATHOGEN-FREE ORGANISMS;

ANIMALIA; RATTUS;

EID: 60349086677     PISSN: 15204081     EISSN: 15227278     Source Type: Journal    
DOI: 10.1002/tox.20391     Document Type: Article

References (52)

1. Abu-Qare AW, Elmasry E, Abou-Donia MB. 2003. A role for P- glycoprotein in environmental toxicology. J Toxicol Environ Health B Crit Rev 6:279-288.
2. Biri A, Bozkurt N, Turp A, Kavutcu M, Himmetoglu O, Durak I. 2007. Role of oxidative stress in intrauterine growth restriction. Gynecol Obstet Invest 64:187-192.
3. Brzezinski MR, Boutelet-Bochan H, Person RE, Fantel AG, Juchau MR. 1999. Catalytic activity and quantitation of cytochrome P-450 2E1 in prenatal human brain. J Pharmacol Exp Ther 289:1648-1653.
4. Burke MD, Prough RA. 1977. Assay of underivatized biphenyl metabolites by high-pressure liquid chromatography. Anal Biochem 83:466-473.
5. Cahill A, Cunningham CC, Adachi M, Ishii H, Bailey SM, Fromenty B, Davies A. 2002. Effects of alcohol and oxidative stress on liver pathology: The role of the mitochondrion. Alcohol Clin Exp Res 26:907-915.
6. Caro AA, Cederbaum AI. 2004. Oxidative stress, toxicology, and pharmacology of CYP2E1. Annu Rev Pharmacol Toxicol 44: 27-42.
7. Chatelain P. 2000. Children born with intra-uterine growth retardation (IUGR) or small for gestational age (SGA): Long term growth and metabolic consequences. Endocr Regul 34:33-36.
8. Coleman T, Antoniak M, Britton J, Thornton J, Lewis S, Watts K. 2004. Recruiting pregnant smokers for a placebo-randomised controlled trial of nicotine replacement therapy. BMC Health Serv Res 4:29.
9. Davies DP, Abernethy M. 1976. Cigarette smoking in pregnancy: Associations with maternal weight gain and fetal growth. Lancet 1:385-387.
10. Dempsey DA, Benowitz NL. 2001. Risks and benefits of nicotine to aid smoking cessation in pregnancy. Drug Saf 24:277-322.
11. Ekstrom G, Ingelman-Sundberg M. 1989. Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1). Biochem Pharmacol 38:1313-1319.
12. Elsayed NM. 2001. Antioxidant mobilization in response to oxidative stress: A dynamic environmental-nutritional interaction. Nutrition 17:828-834.
13. Ernst M, Moolchan ET, Robinson ML. 2001. Behavioral and neural consequences of prenatal exposure to nicotine. J Am Acad Child Adolesc Psychiatry 40:630-641.
14. Fukada A, Saito H, Inui K. 2002. Transport mechanisms of nicotine across the human intestinal epithelial cell line Caco-2. J Pharmacol Exp Ther 302:532-538.
15. Gaertner LS, Murray CL, Morris CE. 1998. Transepithelial transport of nicotine and vinblastine in isolated malpighian tubules of the tobacco hornworm (Manduca sexta) suggests a P-glycoprotein-like mechanism. J Exp Biol 201(Pt 18):2637-2645.
16. Gil S, Saura R, Forestier F, Farinotti R. 2005. P-glycoprotein expression of the human placenta during pregnancy. Placenta 26(2/3):268-270.
17. Gonzalez FJ. 2005. Role of cytochromes P450 in chemical toxicity and oxidative stress: Studies with CYP2E1. Mutat Res 569(1/2):101-110.
18. Guarino AM, Gram TE, Gigon PL, Greene FE, Gillette JR. 1969. Changes in Michaelis and spectral constants for aniline in hepatic microsomes from phenobarbital-treated rats. Mol Pharmacol 5:131-136.
19. Horta BL, Victora CG, Menezes AM, Halpern R, Barros FC. 1997. Low birthweight, preterm births and intrauterine growth retardation in relation to maternal smoking. Paediatr Perinat Epidemiol 11:140-151.
20. Howard LA, Miksys S, Hoffmann E, Mash D, Tyndale RF. 2003. Brain CYP2E1 is induced by nicotine and ethanol in rat and is higher in smokers and alcoholics. Br J Pharmacol 138:1376-1386.
21. Iba MM, Fung J. 1999. Induction of pulmonary cytochrome P4501A1: Interactive effects of nicotine and mecamylamine. Eur J Pharmacol 383:399-403.
22. Iba MM, Fung J, Pak YW, Thomas PE, Fisher H, Sekowski A, Halladay AK, Wagner GC. 1999. Dose-dependent up-regulation of rat pulmonary, renal, and hepatic cytochrome P-450 (CYP) 1A expression by nicotine feeding. Drug Metab Dispos 27:977-982.
23. Ilett KF, Hale TW, Page-Sharp M, Kristensen JH, Kohan R, Hackett LP. 2003. Use of nicotine patches in breast-feeding mothers: Transfer of nicotine and cotinine into human milk. Clin Pharmacol Ther 74:516-524.
24. Kallen K. 2000. Multiple malformations and maternal smoking. Paediatr Perinat Epidemiol 14:227-233.
25. Kapur B, Hackman R, Selby P, Klein J, Koren G. 2001. Randomized, double-blind, placebo-controlled trial of nicotine replacement therapy in pregnancy. Curr Ther Res 62:74-78.
26. Karowicz-Bilinska A. 2004. [Lipid peroxides concentration in women with intrauterine growth restriction]. Ginekol Pol 75:6-9 (in Polish).
27. Karowicz-Bilinska A, Kedziora-Kornatowska K, Bartosz G. 2007. Indices of oxidative stress in pregnancy with fetal growth restriction. Free Radic Res 41:870-873.
28. Kim YJ, Park HS, Park MH, Suh SH, Pang MG. 2005. Oxidative stress-related gene polymorphism and the risk of preeclampsia. Eur J Obstet Gynecol Reprod Biol 119:42-46.
29. Lane RH, Ramirez RJ, Tsirka AE, Kloesz JL, McLaughlin MK, Gruetzmacher EM, Devaskar SU. 2001. Uteroplacental insufficiency lowers the threshold towards hypoxia-induced cerebral apoptosis in growth-retarded fetal rats. Brain Res 895(1/2):186-193.
30. Lankas GR, Wise LD, Cartwright ME, Pippert T, Umbenhauer DR. 1998. Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice. Reprod Toxicol 12:457-463.
31. Li Y, Wang H. 2004. In utero exposure to tobacco and alcohol modifies neurobehavioral development in mice offspring: consideration a role of oxidative stress. Pharmacol Res 49:467-473.
32. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
33. Luck W, Nau H, Hansen R, Steldinger R. 1985. Extent of nicotine and cotinine transfer to the human fetus, placenta and amniotic fluid of smoking mothers. Dev Pharmacol Ther 8:384-395.
34. Mari M, Cederbaum AI. 2000. CYP2E1 overexpression in HepG2 cells induces glutathione synthesis by transcriptional activation of gamma-glutamylcysteine synthetase. J Biol Chem 275: 15563-15571.
35. Mihara M, Uchiyama M. 1978. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 86:271-278.
36. Nakamura Y, Ikeda S, Furukawa T, Sumizawa T, Tani A, Akiyama S, Nagata Y. 1997. Function of P-glycoprotein expressed in placenta and mole. Biochem Biophys Res Commun 235:849-853.
37. Novotna M, Libra A, Kopecky M, Pavek P, Fendrich Z, Semecky V, Staud F. 2004. P-glycoprotein expression and distribution in the rat placenta during pregnancy. Reprod Toxicol 18:785-792.
38. Pennington SN, Sandstrom LP, Shibley IA Jr, Long SD, Beeker KR, Smith CP Jr, Lee K, Jones TA, Cummings KM, Means LW. 1994. Biochemical changes, early brain growth suppression and impaired detour learning in nicotine-treated chicks. Brain Res Dev Brain Res 83:181-189.
39. Schoedel KA, Tyndale RF. 2003. Induction of nicotine-metabolizing CYP2B1 by ethanol and ethanol-metabolizing CYP2E1 by nicotine: Summary and implications. Biochim Biophys Acta 1619:283-290.
40. Smit JW, Huisman MT, van Tellingen O, Wiltshire HR, Schinkel AH. 1999. Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. J Clin Invest 104:1441-1447.
41. Sun M, Kingdom J, Baczyk D, Lye SJ, Matthews SG, Gibb W. 2006. Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation. Placenta 27(6/7):602-609.
42. Takagi Y, Nikaido T, Toki T, Kita N, Kanai M, Ashida T, Ohira S, Konishi I. 2004. Levels of oxidative stress and redox-related molecules in the placenta in preeclampsia and fetal growth restriction. Virchows Arch 444:49-55.
43. Unadkat JD, Dahlin A, Vijay S. 2004. Placental drug transporters. Curr Drug Metab 5:125-131.
44. Utoguchi N, Chandorkar GA, Avery M, Audus KL. 2000. Functional expression of P-glycoprotein in primary cultures of human cytotrophoblasts and BeWo cells. Reprod Toxicol 14: 217-224.
45. Vaglenova J, Birru S, Pandiella NM, Breese CR. 2004. An assessment of the long-term developmental and behavioral teratogenicity of prenatal nicotine exposure. Behav Brain Res 150(1/2):159-170.
46. van Vliet E, Aronica E, Redeker S, Marchi N, Rizzi M, Vezzani A, Gorter J. 2004. Selective and persistent upregulation of mdrlb mRNA and P-glycoprotein in the parahippocampal cortex of chronic epileptic rats. Epilepsy Res 60(2/3):203-213.
47. Vuopio P, Viherkoski M, Nikkila E, Lamberg BA. 1970. The content of reduced glutathione (GSH) in the red blood cells in hypo- and hyperthyroidism. Ann Clin Res 2:184-186.
48. Wu J, Ramesh A, Nayyar T, Hood DB. 2003. Assessment of metabolites and AhR and CYP1A1 mRNA expression subsequent to prenatal exposure to inhaled benzo(a)pyrene. Int J Dev Neurosci 21:333-346.
49. Yan YE, Wang H, Feng YH. 2005. Alterations of placental cyto-chrome P450 1A1 and P-glycoprotein in tobacco-induced intra- uterine growth retardation in rats. Acta Pharmacol Sin 26:1387-1394.
50. Yildiz D. 2004. Nicotine, its metabolism and an overview of its biological effects. Toxicon 43:619-632.
51. Young AM, Allen CE, Audus KL. 2003. Efflux transporters of the human placenta. Adv Drug Deliv Rev 55:125-132.
52. Zhao SC. 1993. [The relation between the levels of serum lipid peroxide, superoxide dismutase and atrial natriuretic peptide in placenta, umbilical cord vein and intrauterine growth retardation in pregnancy induced hypertension]. Zhonghua Fu Chan Ke Za Zhi 28:278-280, 314 (in Chinese).